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After antigen encounter by CD4+ T cells, polarizing
cytokines induce the expression ofmaster regulators
that control differentiation. Inactivation of the histone
methyltransferase Ezh2 was found to specifically
enhance T helper 1 (Th1) and Th2 cell differentiation
and plasticity. Ezh2 directly bound and facilitated
correct expression of Tbx21 and Gata3 in differenti-
ating Th1 and Th2 cells, accompanied by substantial
trimethylation at lysine 27 of histone 3 (H3K27me3).
In addition, Ezh2 deficiency resulted in spontaneous
generation of discrete IFN-g and Th2 cytokine-pro-
ducing populations in nonpolarizing cultures, and
under these conditions IFN-g expression was largely
dependent on enhanced expression of the transcrip-
tion factor Eomesodermin. In vivo, loss of Ezh2
caused increased pathology in a model of allergic
asthma and resulted in progressive accumulation of
memory phenotype Th2 cells. This study establishes
a functional link between Ezh2 and transcriptional
regulation of lineage-specifying genes in terminally
differentiated CD4+ T cells.
INTRODUCTION
Upon encountering antigen, naive CD4+ T cells differentiate into
discrete subsets of effector T helper (Th) cells, a process
controlled by the cytokines present during activation. Th cell
subsets including Th1, Th2, Th9, and Th17 then induce different
types of immune responses (Reiner, 2007; Zhu et al., 2010).
Interferon gamma (IFN-g)-producing Th1 cells are essential for
immunity to intracellular pathogens, and interleukin 4 (IL-4)-,
IL-5-, and IL-13-producing Th2 cells promote immunity to
parasitic worms and also allergic inflammation. Expression of
lineage-specifying transcription factors is required for Th cellIdifferentiation. T-bet (encoded by Tbx21) can induce Th1 cell
differentiation (Szabo et al., 2000), and Gata3 is required and
sufficient for differentiation of Th2 cells (Yamashita et al., 2004;
Zheng and Flavell, 1997). In addition, a transcription factor
related to T-bet called Eomesodermin (Eomes) can also induce
IFN-g production in Th cells under some conditions (Suto
et al., 2006; Tofukuji et al., 2012; Yang et al., 2008). Appropriate
expression of these transcription factors and the effector cyto-
kines they control is therefore essential for proper immunoregu-
lation. Th1 and Th2 cell differentiation programs possess strong
feed-forward mechanisms to maintain polarization (Hosokawa
et al., 2013; Hwang et al., 2005; Usui et al., 2003) and are gener-
ally considered to represent stable lineages of differentiated
effector cells. However, it is also becoming apparent that appre-
ciable levels of functional plasticity exist among the Th cell sub-
sets (Kanno et al., 2012; O’Shea and Paul, 2010).
Epigenetic histonemodifications provide cells with the ability to
maintain specific phenotypic traits independently of changes to
the primary DNA sequence. Several epigenetic modifications
have been found to correlate with gene expression in Th cells (An-
sel et al., 2006; Kanno et al., 2012; Lo¨hning et al., 2002;Nakayama
and Yamashita, 2008; Wei et al., 2009), with repressed genes
frequently associated with increased levels of trimethylation of
lysine 27 on histone 3 (H3K27me3). Polycomb proteins form two
major repressive complexes: polycomb repressive complex 1
(PRC1) and PRC2. Interestingly, CD4+ T cells lacking the PRC1
proteins Mel-18, Bmi1, and Ring1B exhibited impaired differenti-
ation into Th2 cells, partially because of failure of these cells to
inhibit cell death pathways (Kimura et al., 2001; Suzuki et al.,
2010; Yamashita et al., 2008) and also because of the roles of
Bmi1 (Hosokawa et al., 2006) and possibly Mel-18 (Kimura et al.,
2001) in stabilization of the Gata3 protein. The polycomb proteins
Enhancer of Zeste Homolog 1 (Ezh1) and Ezh2 form two closely
related PRC2 complexes that can trimethylate H3K27 and are
required for maintenance of cellular identity at several stages of
development (Di Meglio et al., 2013; Ezhkova et al., 2009; Hira-
bayashi et al., 2009; O’Carroll et al., 2001; Shen et al., 2008; Su
et al., 2003). Ezh2 is highly expressed in CD4+ T cells and binds
to the Gata3 locus prior to Th2 cell differentiation (Onoderammunity 39, 819–832, November 14, 2013 ª2013 Elsevier Inc. 819
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Ezh2 Controls CD4+ T Helper Cell Differentiationet al., 2010). In addition, the position of Ezh2 occupancy at the Il4
and Il13 loci was found to spatially correlate with the presence of
H3K27me3 in Th1 cells (Koyanagi et al., 2005). In contrast, it has
been suggested that Ezh2 is important for efficient actin polymer-
ization and TCR-induced proliferation of peripheral CD4+ T cells,
and this study detected no evidence of decreased H3K27me3 in
unstimulated Ezh2-deficient CD4+ T cells (Su et al., 2005). Addi-
tionally, an unconventional role for Ezh2 in the positive regulation
of cytokine genes in Th cells has been suggested (Jacob et al.,
2008). Thus, it remainsunresolvedwhetherEzh2 retains its canon-
ical role as a genetic repressor in CD4+ T cells.
Here we show that Ezh2 has important functions as a
repressor of gene expression during Th cell differentiation.
Ezh2 bound strongly to genes encoding the transcription factors
T-bet, Eomes, and Gata3, controlled differentiation into Th1
and Th2 effector cells, and regulated plasticity of these subsets
after differentiation. In vivo, Ezh2-deficient (Ezh2DSET/DSET) Th2
cells caused enhanced pathology in a mouse model of allergic
asthma, and CD4+-specific Ezh2 deficiency resulted in progres-
sive accumulation of memory phenotype Th2 cells. These data
indicate that Ezh2 plays an essential role in regulating both differ-
entiation and stability of effector function in CD4+ T cells.
RESULTS
The Histone H3K27 Methyltransferase Ezh2 Controls
Differentiation of Th1 and Th2 Cells
To directly assess the role of Ezh2 during Th cell differentiation,
we used mice in which the Ezh2 SET domain (responsible for
H3K27 methyltransferase activity of Ezh2) was conditionally
deleted (Hirabayashi et al., 2009) in CD4+ T cells by expression
of Cre-recombinase under control of the Cd4 promoter (herein
referred to as Ezh2DSET/DSET or Ezh2-deficient cells). The trun-
cated Ezh2 DSET protein could be detected in Ezh2DSET/DSET
CD4+ T cells, but expression was much lower compared to the
levels of native Ezh2 in wild-type (WT) cells (Figure S1A available
online). Mice with CD4+ T cell-specific Ezh2 deficiency (6 weeks
old, young adult) had normal proportions of CD4+ and CD8+
T cells in the spleen and thymus (Figure S1B) and normal expres-
sion of T cell-associated surface markers on CD4+ T cells (Fig-
ure S1C). In addition, we did not observe any defects in IL-2
production (Figure S1D) or initial proliferation of Ezh2DSET/DSET
CD4+ T cells (Figures S1E andS1F).We first investigatedwhether
loss of Ezh2 could affect Th cell differentiation. Ezh2-deficient Th
cells produced markedly more IFN-g in cultures with titrated
doses of the Th1 cell-inducing cytokine IL-12 (Figures 1A and
1C). Likewise, more IL-4, IL-5, and IL-13 were produced in cul-
tures with the Th2 cell-inducing cytokine IL-4 (Figures 1B and
1D). Interestingly, enhanced IFN-g production by Ezh2-deficient
cells was still observed without addition of IL-12, and this could
be inhibitedby IL-4 (Figure 1B). In addition, compared toWTcells,
increased amounts of IFN-g, IL-4, IL-5, and IL-13 were produced
by Ezh2-deficient CD4+ T cells activated via the TCR without any
exogenously added cytokines (Figure 1E). Importantly, as shown
by intracellular staining, themajority of IFN-g- and IL-4-producing
cells were mutually exclusive, indicating that loss of Ezh2 does
notdisable Thcell polarization (Figures1Aand1B).Wealso inves-
tigated the effect of 3-Deazaneplanocin A (DZNep), a specific in-
hibitor of histone methyltransferase activity. This agent has been820 Immunity 39, 819–832, November 14, 2013 ª2013 Elsevier Inc.shown to inhibit Ezh2 and reactivate polycomb repressed genes
in cancer cells (Tan et al., 2007) and to preferentially decrease
H3K27me3 in T lymphocytes (He et al., 2012). Treatment of
CD4+ T cells with low concentrations of DZNep (7.5 and 15 nM)
during differentiation resulted in a dose-dependent increase in
the production of IFN-g or of IL-4, IL-5, and IL-13 under Th1 or
Th2 cell-inducing conditions, respectively (Figures 1F and 1G).
These data indicate that inhibition of Ezh2 activity via genetic
inactivation or chemical inhibition strongly enhances cytokine
production and differentiation of Th1 and Th2 cells.
Loss of Ezh2 Results in Enhanced Th1 and Th2 Cell
Polarization with Increased Expression of T-bet and
Gata3
Todeterminewhether cytokine expression in Ezh2-deficient cells
coincided with expression of lineage-specifying transcription
factors at the single-cell level, we analyzed expression of T-bet
together with IFN-g and of Gata3 together with IL-4 (Figures 2A
and 2B). Ezh2-deficient cells again showed markedly increased
cytokine production. Importantly, those cells that produced
IFN-g also expressed higher amounts of T-bet, and the cells
that produced IL-4 expressed higher amounts of Gata3. We
also found enhanced expression of Tbx21 and Gata3 mRNA at
all of the concentrations of polarizing cytokines tested (Figures
2C and 2D). To further analyze the contribution of T-bet to
the enhanced IFN-g production by Ezh2-deficient cells, we
compared WT, Tbx21/, Ezh2DSET/DSET, and cells doubly defi-
cient for Ezh2 and T-bet (Ezh2DSET/DSETTbx21/) differentiated
under Th1 cell-inducing conditions. We detected an approxi-
mate 50% reduction in IFN-g production by Tbx21/
Th1 cells compared to WT cells, and again IFN-g production by
Ezh2DSET/DSET cells was markedly enhanced. In double-deficient
Ezh2DSET/DSETTbx21/ cells, the enhanced IFN-g production
induced by loss of Ezh2 was substantially reduced (Figure 2E),
indicating that the increased expression of IFN-g in Th1 polarized
Ezh2-deficient cells is largely dependent on T-bet. To assess the
contribution of Gata3 to Th2 cytokine production, we usedGata3
siRNA to knock down Gata3 expression in Ezh2-deficient cells
differentiated under Th2 cell polarizing conditions. Gata3 siRNA
abolished IL-4, IL-5, and IL-13 production by Ezh2-deficient
Th2 cells (Figure 2F). These data indicate that Gata3 is required
for enhanced Th2 cytokine production in cells lacking Ezh2 and
confirm that Ezh2-deficient cells are unable to bypass the
requirement for Gata3 in Th2 cytokine expression. In contrast
to the large enhancement of Th1 and Th2 cell differentiation, we
detected only a very small increase in IL-17 production when
comparing WT and Ezh2-deficient cells differentiated under
Th17 cell-inducing conditions, and the expression of Rorgt was
also only slightly increased (Figures S2A and S2B). In addition,
we found no enhancement, but rather a decrease in differentia-
tion into Th9 and iTreg cells by Ezh2-deficient CD4+ T cells (Fig-
ures S2CandS2D). Interestingly, under Th17, Th9, and also iTreg
cell-inducing conditions, we again detected more IFN-g produc-
tion by Ezh2-deficient cells compared to WT cells.
Genome-wide Analysis of Ezh2 Binding in Th1 and Th2
Cells
To globally determine the genes most likely to regulate the
enhanced Th1 and Th2 cytokine production by Ezh2-deficient
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Figure 1. Loss of Ezh2 Function Results in Enhanced Th1 and Th2 Cell Differentiation
(A–D) Naive wild-type (WT) or Ezh2-deficient (Ezh2DSET/DSET) CD4+ T cells differentiated under Th1 (A and C) or Th2 (B and D) cell-inducing conditions with the
indicated concentrations of IL-12 or IL-4, respectively.
(E) Naive CD4+ T cells activated with anti-TCRb alone for the indicated times.
(F and G) Naive CD4+ T cells were cultured under Th1 cell-inducing conditions with 0.1 ng/ml IL-12 (F) or Th2 cell-inducing conditions with 1 ng/ml IL-4 (G) and the
indicated concentrations of the Ezh2 inhibitor DZNep.
Cytokine production measured by cytoplasmic staining of IL-4 and IFN-g or IL-5 and IL-13 after 5 hr restimulation with anti-TCRb (A, B, F, and G) and ELISA after
24 hr restimulation with anti-TCRb (C and D) or the indicated time of culture (E) (n = 3, mean ± SD). Data are representative of at least three independent
experiments. *p < 0.05, **p < 0.01. See also Figure S1.
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Ezh2 Controls CD4+ T Helper Cell DifferentiationTh cells, we used transcriptional profiling of Ezh2-deficient Th
cells combinedwith genome-widemapping of Ezh2 target genes
inWT Th1 and Th2 cells. Ezh2 deficiency resulted in 856 upregu-Ilated and 908 downregulated genes in nonpolarized Th cells.
Gene ontology (GO) analysis (Huang et al., 2009) of the upregu-
lated genes showed that the most statistically overrepresentedmmunity 39, 819–832, November 14, 2013 ª2013 Elsevier Inc. 821
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Figure 2. Loss of Ezh2 Results in Enhanced Expression of the Master Regulators T-bet and Gata3
(A–D) Naive WT or Ezh2DSET/DSET CD4+ T cells differentiated under Th1 (A and C) or Th2 (B and D) cell-inducing conditions with the indicated concentrations of
IL-12 or IL-4, respectively. mRNA expression of Tbx21 (T-bet) (C) and Gata3 (D), n = 3, mean ± SD. **p < 0.01.
(E)NaiveWT,Tbx21/,Ezh2DSET/DSET,andEzh2DSET/DSETTbx21/double-deficientCD4+TcellsdifferentiatedunderTh1cell-inducingconditionswith0.1ng/ml IL-12.
(F) Naive CD4+ T cells differentiated under Th2 cell-inducing conditions with 1 ng/ml of IL-4 and electroporated with control siRNA (WT and Ezh2DSET/DSET cells) or
Gata3 siRNA (Ezh2DSET/DSET cells).
CytoplasmicstainingofT-betwith IFN-g (A) andGata3with IL-4 (B),meanfluorescence intensities (MFIs) ofT-bet andGata3areshown (WTcells,blue;Ezh2DSET/DSET
cells, red) and IL-4 with IFN-g (E and F) and IL-5 with IL-13 (F). Data are representative of at least three independent experiments. See also Figure S2.
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Ezh2 Controls CD4+ T Helper Cell Differentiationgroups were involved in immune responses (immune system
process; GOTERM_BP, p = 1.53 1019, 96 genes), with approx-
imately half encoding cytokines and their receptors (cytokine-
cytokine receptor interaction; KEGG pathway, p = 2.5 3 1013,
44 genes). This indicates that cellular context is important in
determining which genes are derepressed when Ezh2 is absent,
a phenomenon that has also been reported in other studies (Ezh-
kova et al., 2009; Hirabayashi et al., 2009). Of the genes defined
in reference genome mm9 in the RefSeq database, 9.5% (1,998
genes) were bound by Ezh2 in both Th1 and Th2 cells, 1.1% (240
genes) were bound in Th1 cells only, and 2.0% (415 genes) were822 Immunity 39, 819–832, November 14, 2013 ª2013 Elsevier Inc.bound in Th2 cells only (Figure S3A). GO analysis of all bound
genes showed very strong enrichment of genes involved in
development (developmental process; GOTERM_BP, p =
5.1 3 10117, 743 genes) and transcription (transcription factor
activity; GOTERM_MF, p = 1.1 3 1087, 308 genes), similar to
that reported for polycomb proteins in embryonic stem cells
(Boyer et al., 2006). Ezh2 binding was detected at 16.0% (137
of 856 genes) of the upregulated genes and also at 6.6% (60
of 908 genes) of the downregulated genes. Ezh2 binding
was significantly more likely to be detected at genes upregu-
lated in response to inactivation of Ezh2 (chi-square test,
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Figure 3. Global Analysis of Ezh2 Function
and Localization by Gene Expression and
ChIP-Seq Analysis
(A and B) Scatter plots depicting Ezh2 binding
in Th1 cells (x axes) and Th2 cells (y axes) for all
genes upregulated (A) and downregulated (B) in
Ezh2DSET/DSET nonpolarized Th cells. Blue dots
indicate greater than 2-fold enrichment of Ezh2
binding with Tbx21, Eomes, and Gata3 (shown
in red).
(C andD)Upregulated genes encoding transcription
factors (C) and cytokines and cytokine receptors
(D) in Ezh2DSET/DSET nonpolarized Th cells. Left col-
umn, fold upregulation (red); middle columns, Ezh2
binding in WT Th1 and Th2 cells (orange); right col-
umn, log2 ratio of Ezh2bindingbetweenWTTh1and
Th2 cells (Th1 high, green; Th2 high, purple).
See also Figure S3.
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Ezh2 Controls CD4+ T Helper Cell Differentiationp = 7.33 108); however, the presence of Ezh2 at a small subset
of the downregulated genes also indicates that Ezh2 could play a
more complex role in gene regulation at some loci. Ezh2 binding
intensity in Th1 versus Th2 cells at all genes up- and downregu-
lated by inactivation of Ezh2 are depicted; genes with more than
2-fold enrichment of Ezh2 are indicated in blue (Figures 3A and
3B and Table S1 and S2), with the transcription factors Gata3,
Tbx21, and Eomes indicated in red. Based on our results by
GO analysis, we then assessed the upregulated genes encodingImmunity 39, 819–832, Ntranscription factors (44 genes) (Figure 3C)
and cytokines and cytokine receptors (47
genes) (Figure 3D) in more detail. Overall,
transcription factor genes showed signifi-
cantly higher Ezh2 binding (Student’s
t test, p = 0.003). The lineage-specifying
genes Tbx21 and Gata3, and another
gene with unknown function in Th1 or
Th2 cells called Epas1 (Figure 3C, arrows),
showed the most dramatic changes in
Ezh2 occupancy during differentiation. In
Th1 cells, Ezh2 also preferentially bound
genes encoding several cytokines pro-
duced by Th2 cells including IL-4, IL-5,
IL-10, IL-13, and IL-24; however, Ezh2
occupancy at these loci was very low (Fig-
ure 3D, arrows). Loss of Ezh2 also resulted
in increased expression of Maf, another
transcription factor associated with regu-
lation of Th2 cytokine expression; how-
ever, this gene did not appear to be a
strong target of Ezh2, and there was no
difference in Ezh2 binding at this loci in
Th1 cells compared to Th2 cells (Fig-
ure S3B). As expected, no difference in
Ezh2 binding between Th1 and Th2 cells
was found at the Ifng gene; however,
ChIP-seq analysis identified an area be-
tween 40 and 50 kb downstream of the
Ifng gene that showed moderately higher
Ezh2 binding in Th2 cells (Figure S3B), anarea that may be functionally important for Ifng gene regulation
(Schoenborn et al., 2007). We also found preferential Ezh2 bind-
ing in Th2 cells at genes encoding several surface receptors
normally expressed on Th1 cells including Cxcr3, Ccr5, Cd70,
Il18r1, Il18rap, and Il12rb2 and the chemokine Ccl5 (Figure 3D,
arrows). Ezh2 ChIP-seq profiles for Gata3, Epas1, Maf, Tbx21,
Eomes, Th2 cytokine, and Ifng loci are shown in Figure S3B.
These data indicate that Ezh2 is dynamically regulated at several
of the signature genes that define the Th1 and Th2 cellovember 14, 2013 ª2013 Elsevier Inc. 823
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Figure 4. Dynamic Changes in Ezh2 Binding
and H3K27me3 Occur during Th1 and Th2
Cell Differentiation
Ezh2-ChIP and H3K27me3-ChIP on WT CD4+
naive, Th1, and Th2 cells (A–D), and H3K27me3-
ChIP on WT and Ezh2DSET/DSET nonpolarized Th
cells with WT Th1 and Th2 cells for comparison
(E–H), for Gata3 (A and E), Tbx21 (B and F), Th2
cytokine (C and G), and Ifng (D and H) loci
measured by qPCR (n = 3, mean ± SD). Schematic
representations of each gene loci show the posi-
tions of the primers used for detection relative to
the transcriptional start site of each gene. Data are
representative of three independent experiments.
*p < 0.05, **p < 0.01; Abbreviation: pro., promoter.
See also Figure S4.
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Ezh2 Controls CD4+ T Helper Cell Differentiationdifferentiation programs. Moreover, it confirms that Tbx21 and
Gata3 display comparatively stronger binding of Ezh2 and that
these genes are among those that display the most dramatic dif-
ferences in Ezh2 occupancy during differentiation.
Ezh2 Bound Directly to the Genes Encoding T-bet and
Gata3 and Deficiency of Ezh2 Resulted in Loss of
H3K27me3 at These Loci
To determine whether Ezh2 was lost after differentiation or re-
cruited toGata3 and Tbx21 loci, we performed ChIP onWT naive
CD4+ T cells and differentiated Th1 and Th2 cells. Ezh2 binding824 Immunity 39, 819–832, November 14, 2013 ª2013 Elsevier Inc.was detected at the Gata3 locus in naive
and Th1 cells, which was dramatically
diminished in Th2 cells (Figure 4A).
A similar but reciprocal regulation was
observed at the Tbx21 locus where bind-
ing was detected in naive and Th2
cells but was absent in Th1 cells (Fig-
ure 4B). We also used H3K27me3-spe-
cific ChIP to assess the presence of the
H3K27me3 modification at these loci in
WT cells and found strong positive corre-
lations between the level of Ezh2 binding
and H3K27me3 (Pearson’s correlation
coefficient for Gata3 locus r = 0.95, p <
0.0001 and Tbx21 locus r = 0.77, p =
0.007) (Figures 4A and 4B). In agreement
with the ChIP-seq data, we detected rela-
tively little Ezh2 binding at the Th2 and
Ifng cytokine loci compared to that
observed for Gata3 and Tbx21 (Figures
4C and 4D). Interestingly, we did detect
H3K27me3 associated with the Th2 and
Ifng cytokine loci (Figures 4C and 4D),
and H3K27me3 was lost at the Th2 cyto-
kine loci in Th2 cells and at the Ifng locus
in Th1 cells. At the Rad50 promoter, an
unrelated gene within the Th2 cytokine
loci, we did not detect any differences
in Ezh2 occupancy or H3K27me3 (Fig-
ure 4C), nor did we detect any differences
in total H3 during differentiation at any ofthese genes (data not shown). Therefore, at the Gata3 and
Tbx21 loci, differential binding of Ezh2 and the associated
H3K27me3 modification in differentiated cells appears to be
accomplished primarily via loss of high levels of pre-existing
Ezh2 in naive CD4+ T cells. In contrast, both Ezh2 and
H3K27me3 are maintained during the process of activation
and cell division at lineage-specifying genes of the opposing
Th cell subtype. Compared to the Gata3 locus, Ezh2 occupancy
and H3K27me3 at the Il17a and Rorc loci in Th cells activated
without polarizing cytokines and in Th cells polarized under
Th17 cell-inducing conditions were very low (Figure S4A). As
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Ezh2 Controls CD4+ T Helper Cell Differentiationexpected, association of Ezh2with theGata3 and Tbx21 loci was
dramatically reduced in Ezh2DSET/DSET Th cells (Figures S4B and
S4C). To determine whether a functional link exists between the
presence of Ezh2 and H3K27me3, we assessed H3K27me3 at
the Gata3, Tbx21, Th2, and Ifng cytokine loci. In nonpolarized
Ezh2-deficient cells, we found that H3K27me3 was depleted at
both transcription factor and cytokine loci, indicating that Ezh2
was required for the presence of H3K27me3 at both transcription
factor and cytokine genes (Figures 4E–4H).
Ezh2-Mediated Repression of T-bet and Eomes Is
Required to Control Spontaneous Generation of
IFN-g-Producing T Cells
Enhanced production of Th1 and Th2 cytokines was observed
at varying levels, even in cultures without exogenously added
polarizing cytokines (Figures 1 and 2). We next analyzed in
more detail the mechanism through which Ezh2 controls cyto-
kine production in nonpolarized Th cell cultures with neutralizing
antibodies to both IL-4 and IFN-g. WT nonpolarized Th cells did
not produce appreciable levels of Th1 or Th2 cytokines, but a
substantial percentage of Ezh2-deficient cells produced IFN-g
(42.1%) and smaller percentages produced IL-4 and IL-13
(3.4% and 17.3%, respectively) (Figure 5A). These data confirm
that loss of Ezh2 results in deregulation of both Th1 and to a
lesser extent Th2 effector cell subtypes in the absence of exog-
enous polarizing signals. In nonpolarized Ezh2-deficient Th cells,
Tbx21 mRNA was increased 11.3-fold, there was a large 49.5-
fold increase in the expression of the related T-box transcription
factor gene Eomes, and there was a more modest 3.1-fold
increase in Gata3 expression (Figure 5B). Corresponding in-
creases in expression of T-bet, Eomes, and Gata3 proteins
were also detected by intracellular staining and flow cytometry
(Figure 5C).
To determine the relative contribution of Ezh2-mediated
repression of Tbx21 and Eomes to the deregulated IFN-g
expression by Ezh2 KO cells, we next compared Th cells doubly
deficient in Ezh2 and T-bet with Th cells doubly deficient in Ezh2
and Eomes (Ezh2DSET/DSETEomesDExon1/DExon1). Interestingly,
cells doubly deficient in Ezh2 and T-bet produced only moder-
ately less IFN-g under nonpolarized conditions compared to
Ezh2-deficient cells (Figures 5D and S5A), indicating that T-bet
plays only a minor role in the spontaneous production of IFN-g
by Ezh2-deficient Th cells. In contrast, in cultures with exoge-
nously added IL-12, the enhancement of IFN-g production
induced by loss of Ezh2 was more dependent on T-bet (Figures
2E and S5A). We next analyzed the contribution of Eomes to the
enhanced production of IFN-g by both nonpolarized and Th1
polarized Ezh2-deficient cells. Nonpolarized Ezh2-deficient Th
cells again produced IFN-g, but strikingly, the spontaneous pro-
duction of IFN-g was completely lost in Th cells doubly deficient
in Ezh2 and Eomes (Figures 5E, top, and S5A), indicating that
Ezh2-mediated repression of Eomes is essential to avoid spon-
taneous production of IFN-g. In contrast, Ezh2 and Eomes dou-
ble deficiency had only a mild effect on the production of IFN-g
induced by IL-12 (Figures 5E, bottom, and S5A). Therefore,
Ezh2-mediated repression of both T-bet and Eomes is required
to efficiently control IFN-g production by activated Th cells.
Ezh2 appears to modulate the sensitivity of Th cells to IL-12
via control of the Tbx21 locus, and Ezh2 is also required toIrepress the Eomes locus to avoid spontaneous expression
of IFN-g.
In nonpolarized Th cells, we detected large amounts of
H3K27me3 at the Eomes locus, and this modification was lost
in the absence of Ezh2 (Figure 5F). As expected, the presence
of Ezh2 at the Eomes locus was not detected in Ezh2DSET/DSET
Th cells (Figure 5G). To further investigate possible mechanisms
regulating the upregulation of Eomes in Ezh2-deficient Th cells,
we next measured histone acetylation (ac), an epigenetic modi-
fication associated with accessible chromatin structure and
active transcription. We found that both H3K9ac (Figure 5H)
and H3K27ac (Figure 5I) were increased at the Eomes locus in
cells lacking Ezh2. Both p300 and CBP contain a histone acetyl-
transferase (HAT) domain and form a coactivation complex that
can recruit RNA polymerase and enhance gene expression. We
found higher binding of both of these proteins to theEomes locus
in Ezh2-deficient cells (Figures 5J and 5K). We also detected
modestly enhanced histone acetylation and accumulation of
p300 and CBP at the Tbx21 locus in Ezh2-deficient cells
compared to WT cells (Figures S5B–S5E). It is therefore likely
that the p300/CBP HAT complex plays a role in the spontaneous
enhancement of Eomes and possibly Tbx21 expression in the
absence of Ezh2 function.
Ezh2-Deficient Th Cells Display Enhanced Plasticity
We next investigated whether Ezh2 was also involved in regu-
lating themaintenance of CD4+ T cell phenotype after specializa-
tion into effector Th1 or Th2 cells. WT and Ezh2-deficient CD4+
T cells were differentiated into Th1 or Th2 cells for 3 days
(primary culture) and then cells were cultured under the opposite
conditions for a further 2 days (secondary culture) and assessed
for their ability to produce effector cytokines. Very little produc-
tion of IL-4 or IL-5 was detected in WT or Ezh2-deficient primary
Th1 cell cultures, but Ezh2-deficient cells could still produce
some IL-13 (Figure 6A). In contrast, when polarized Th1 cells
were exposed to Th2 cell-inducing secondary culture, we
observed much stronger induction of IL-4, IL-5, and IL-13 in
Ezh2-deficient cells compared to WT cells (4.8, 7.6, and 8.8
times, respectively) (Figure 6A). In addition, compared to WT
cells, we detected increased IFN-g production by Th2 polarized
Ezh2-deficient cells, and this was further enhanced in response
to secondary culture under Th1 cell-inducing conditions (2.8
times) (Figure 6B). We next stained WT and Ezh2-deficient Th2
cells with both IFN-g and IL-4. Polarized Ezh2-deficient Th1 cells
could be readily induced to express IL-4, IL-5, and IL-13 when
exposed to Th2 cell-inducing culture conditions (Figure 6C).
Importantly, we detected both single- and double-positive pop-
ulations in cells lacking Ezh2, indicating that IFN-g-producing
Th1 cells were induced to express IL-4 in the absence of Ezh2
function. Similar plasticity in cytokine production was observed
in Ezh2-deficient Th2 cells; when exposed to Th1 cell-inducing
conditions, Ezh2-deficient Th2 cells expressed IFN-g and a
large percentage of these cells produced both IFN-g and IL-4
(Figure 6D). In contrast to the instability observed in both Th1
and Th2 cell differentiation programs, stable repression of
Th17 cell differentiation by Th1 cells was not affected by loss
of Ezh2 (Figure S6A).
WT and Ezh2-deficient Th1 cells expressed similar levels of
Gata3; however, after exposure to Th2 cell-inducing conditions,mmunity 39, 819–832, November 14, 2013 ª2013 Elsevier Inc. 825
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Figure 5. Ezh2-Mediated Repression of T-bet and Eomes Is Required to Control IFN-g Production by Th Cells
(A–C) Naive WT and Ezh2DSET/DSET CD4+ T cells differentiated under nonpolarizing conditions (with both anti-IL-4 and anti-IFN-g neutralizing antibodies) followed
by cytoplasmic staining of the indicated cytokines after 5 hr restimulation with anti-TCRb (A, top) and combined results from five independent experiments (A,
bottom), mRNA encoding Tbx21, Eomes, andGata3 (B), and protein expression of T-bet, Eomes, and Gata3 with MFIs shown (WT, blue; Ezh2DSET/DSET, red) and
9,000 events displayed for each sample (C).
(D and E) Naive WT, Ezh2DSET/DSET, and Ezh2DSET/DSETTbx21/ double-deficient (D) or naive WT, Ezh2DSET/DSET, and Ezh2DSET/DSETEomesDExon1/DExon1 double-
deficient (E) CD4+ T cells differentiated under nonpolarizing (top) or Th1 cell-inducing conditions with 1 ng/ml IL-12 (bottom), and cytokine production measured
by cytoplasmic staining of IL-4 and IFN-g after 5 hr restimulation with anti-TCRb.
(F–K) ChIP analysis for the indicated histone modifications and chromatin-modifying proteins at the Eomes locus in WT and Ezh2DSET/DSET nonpolarized Th cells.
n = 3, mean ± SD. Data are representative of at least three independent experiments, *p < 0.05. **p < 0.01. See also Figure S5.
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Figure 6. Loss of Ezh2 Results in Enhanced Plasticity of Th1 and Th2 Cells
Naive CD4+ T cells were polarized for 3 days under Th1 (A, C, and E) or Th2 (B, D, and F) cell-inducing conditions with 10 or 100 ng/ml of IL-12 or IL-4, respectively,
and then recultured under the same condition or under the opposing condition for a further 2 days as indicated.
(A and B) Production of IL-4, IL-5, and IL-13 (A) and IFN-g (B) measured by ELISA after 24 hr restimulation with anti-TCRb, n = 3, mean ± SD.
(C–F) Cytoplasmic staining for IFN-g with IL-4 (C and D) or IL-5 with IL-13 (C) and Gata3 alone (E), or T-bet alone (F) after 5 hr restimulation with anti-TCRb.
(E and F) Histograms at left with 9,000 events displayed for each sample (WT, blue; Ezh2DSET/DSET, red), and right panels show combined MFI results from five
independent experiments.
All other data are representative of at least three independent experiments. **p < 0.01. See also Figure S6.
Immunity
Ezh2 Controls CD4+ T Helper Cell Differentiationwe observed a large increase in Gata3 expression in Ezh2-defi-
cient Th1 cells (Figures 6E). Expression of T-bet was also higher
in Ezh2-deficient compared toWT Th2 cells, and this was further
enhanced by exposure to Th1 cell-inducing conditions (Figures
6F). Eomes was not expressed by Th2 cells after exposure to
Th1 cell-inducing conditions (data not shown). Double staining
of Gata3 with IL-4 showed a large increase in the number ofIEzh2-deficient cells coexpressing Gata3 and IL-4 after Th2
cell-inducing secondary culture (Figure S6B). Ezh2 deficiency
also enhanced the numbers of Th2 cells that coexpressed
IFN-g and T-bet after Th1 cell-inducing secondary culture (Fig-
ure S6C). These results show that both Th1 and Th2 cells lacking
Ezh2 display considerably greater plasticity when compared to
cells with intact Ezh2 function.mmunity 39, 819–832, November 14, 2013 ª2013 Elsevier Inc. 827
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Figure 7. Th Cells Lacking Ezh2 Mediate Enhanced Type 2 Immune Responses In Vivo
(A–D) OVA-specificWT or Ezh2DSET/DSET Th2 cells were transferred to syngeneicWTC57BL/6mice that were then challengedwith anOVA aerosol. Total numbers
of eosinophils (Eos), neutrophils (Neu), lymphocytes (Lym), and macrophages (Mac) recovered by bronchoalveolar lavage (BAL) (A) and indicated cytokines in
cell-free BAL samples measured by ELISA (B). Representative images from lung tissue sections stained with periodic acid Schiff’s reagent with mucus stained
magenta; scale bars represent 60 mm (C). Muc5ac and Gob5 mRNA expression in lung tissue measured by qRT-PCR (D).
(E–G) Untreated WT or Ezh2DSET/DSET mice analyzed for CD44hiCD62Llo spleen CD4+ T cells by flow cytometry (E), and cytokine production by CD44hiCD62Llo
spleen CD4+ T cells stimulated with anti-TCRb for the indicated times (F) and total serum IgE (G) measured by ELISA.
n = 5–6 mice/group (A–D); n = 11 mice/group (G); and n = 3 replicates (F) (all mean ± SEM). Data are representative of at least two independent experiments. *p <
0.05, **p < 0.01. In (E), p value determined by analysis of covariance. See also Figure S7.
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Ezh2 Controls CD4+ T Helper Cell DifferentiationLoss of Ezh2 Results in Enhanced Asthma-like
Pathology and Accumulation of Th2 Memory Phenotype
Cells In Vivo
Finally, to investigate the physiological consequences of Ezh2-
mediated regulation of Th cell function, in vitro generated oval-
bumin (OVA)-specific Th2 cells (Figure S7A) were intravenously
transferred into WT C57BL/6 mice, and these mice were then
challenged with aerosolized OVA. Compared to mice that
received WT cells, recipients of Ezh2-deficient cells displayed
increased eosinophilic inflammation in the airways, as assessed
by bronchoalveolar lavage (BAL) (Figure 7A). In addition, mice
that received Ezh2-deficient cells had higher levels of the Th2
cytokines IL-4, IL-5, and IL-13 in BAL samples (Figure 7B), and
thesemice displayed enhanced pathology andmucus hyperpro-
duction in the lungs and higher expression of mRNA forMuc5ac
and Clca3 (Gob5) (Figures 7C and 7D).828 Immunity 39, 819–832, November 14, 2013 ª2013 Elsevier Inc.In untreated mice maintained under specific-pathogen-free
(SPF) conditions, we observed a progressive increase in the
proportion of effector memory phenotype (CD44hiCD62Llo)
CD4+ T cells that was greatly exaggerated in mice with CD4+
T cell-specific Ezh2 deficiency and accounted for approxi-
mately 70% of the CD4+ T cells in the spleens of these mice
by 6 months of age (Figure 7E). Interestingly, purified
Ezh2-deficient effector memory phenotype CD4+ T cells from
12-week-old mice produced markedly increased amounts of
the Th2 cytokines IL-4, IL-5, and IL-13 but not IFN-g when
compared to WT effector memory phenotype cells (Figures
7F and S7B). Large increases in IgE were also detected in
serum from 6-month-old mice with CD4+ T cell-specific Ezh2
deficiency (Figure 7G). Thus, Th2 cells lacking Ezh2 generate
exaggerated type 2 biased immune responses in a mouse
model of allergic asthma, and loss of Ezh2 function in CD4+
Immunity
Ezh2 Controls CD4+ T Helper Cell DifferentiationT cells results in enhanced accumulation of memory type Th2
cells in vivo.
DISCUSSION
The ability of CD4+ T cells to rapidly specialize into distinct
subsets with defined functions is a critical aspect of immunoreg-
ulation. We have identified the polycomb protein Ezh2 as an
essential regulator of Th1 and Th2 cell responses, both during dif-
ferentiation and as a stabilizer of Th cell phenotype after special-
ization. Ezh2 directly bound and regulated correct expression of
Tbx21 andGata3 in developing Th1 and Th2 cells, and Ezh2 bind-
ing at these loci was accompanied by substantial H3K27me3.
Ezh2 also constrained spontaneous generation of IFN-g-produc-
ing cells, mainly by repressing expression of Eomes. In vivo,
loss of Ezh2 enhanced Th2 cell-induced pathology in a model of
allergic asthma and in untreated animals resulted in progressive
accumulation of memory phenotype Th2 cells.
Ezh2 bound strongly to Tbx21 and Gata3, and these two mas-
ter regulators displayed the highest levels of differential binding
between Th1 and Th2 cells. In addition, we detected strong bind-
ing of Ezh2 to the gene Eomes that encodes another T-box tran-
scription factor closely related to T-bet. Inactivation of Ezh2
resulted in a profound reduction in H3K27me3, confirming that
in CD4+ T cells functional Ezh2 is required for maintenance of
H3K27me3 at each of these loci. However, it should be noted
that although Ezh2 occupancy at genes encoding the Th1
and Th2 cytokines was at the lower limits of detection in
both ChIP-PCR and ChIP-seq assays, we could still detect
H3K27me3 at these loci that was lost in cells deficient in Ezh2.
This may indicate that very low levels of Ezh2 binding could still
have some control over H3K27me3 at these loci. Based on the
results obtained with Th cells doubly deficient in Ezh2 together
with T-bet or Ezh2 together with Eomes, Ezh2-mediated regula-
tion of sensitivity to IL-12-induced Th1 cell polarization and
spontaneous generation of IFN-g-producing cells can be largely
explained by the repression of Tbx21 and Eomes expression.
However, Th1 cells lacking T-bet could still produce appreciable
amounts of IFN-g, a result that has also been shown previously
(Usui et al., 2006) and attributed to a decreased requirement
for T-bet when IL-4 signals are neutralized. Likewise, Th cells
doubly deficient in Ezh2 and T-bet could still produce significant
amounts of IFN-g, indicating that Ezh2 could also be involved in
the regulation of other IFN-g-inducing genes or the Ifng locus
itself. It is also possible that Ezh2-mediated repression of
Gata3 together with repression of other loci such as the Th2
cytokine genesmay contribute to the control of Th2 cell polariza-
tion. We also detected enhanced expression of c-Maf (encoded
byMaf) in Ezh2-deficient Th cells. However,Maf does not appear
to be a direct target of Ezh2, and no difference in Ezh2 binding at
this locus was detected in Th1 compared to Th2 cells, indicating
that Maf may be indirectly regulated in cells lacking Ezh2
function.
During differentiation of Ezh2-deficient Th cells, Tbx21 and
Gata3 were more sensitive to upregulation in response to polar-
izing cytokines. This phenotype contrasts with that observed for
T cells lacking DNA methyltransferase (Dnmt1), where dysregu-
lated expression of IL-4 appears to be independent of Gata3
expression (Makar et al., 2003).Moreover, repression of cytokineIproduction by Dnmt3a appears to depend on de novo methyl-
ation at the Il4, Il13, and Ifng loci (Thomas et al., 2012;
Yu et al., 2012). In contrast, our data show that Ezh2-deficient
cells maintain the ability to polarize into Th1 or Th2 cell subsets,
accompanied by upregulation of the corresponding master
regulator. Therefore, histone methyltransferases and DNA
methyltransferases appear to control Th cell function through
the regulation of distinct target genes. Interestingly, it was
recently found that the SUV39H1-H3K9me3-HP1a pathway is
also required to maintain Th2 cell stability and that loss of
SUV39H1 changes the ratio of H3K9ac to H3K9me3 at the Ifng
locus (Allan et al., 2012). In addition to directly binding to
Tbx21, Eomes, and Gata3, we found that Ezh2 inhibited sponta-
neous accumulation of the HAT coactivator proteins p300 and
CBP and of H3K9ac and H3K27ac at the Tbx21 and Eomes loci.
Ezh2 does not appear to play a major role in the repression of
other Th cell differentiation programs. Th17 cell polarization and
stable repression of Th17 cell differentiation are less sensitive to
loss of Ezh2, and Th9 cell and iTreg cell differentiation is actually
inhibited in the absence of Ezh2. Impaired differentiation of
Ezh2-deficient Th9 and iTreg cells may be due to the inability
of these cells to repress IFN-g, leaving open the possibility that
Ezh2 may have important as yet undiscovered effects on differ-
entiation of these cell types. In contrast to Tbx21, Eomes, and
Gata3, Ezh2 does not appear to target the master regulators of
other lineages, specifically Rorc (Th17 cells), Foxp3 (iTreg cells),
or Sfpi1 or Irf4 (Th9 cells). Eomes may control IFN-g expression
byCD4+ T cells under some circumstances (Suto et al., 2006; To-
fukuji et al., 2012; Yang et al., 2008), but Eomes is not highly
expressed in IL-12-induced Th1 cells. Our data indicate that
Ezh2-mediated repression of Eomes is essential to inhibit spon-
taneous expression of IFN-g production when not directly in-
hibited by other Th cell differentiation programs. It will therefore
be important to further investigate the functional role for Ezh2-
mediated repression of Eomes in other Th cell subsets.
We also found that Ezh2-deficient Th cells were capable of
causing enhanced airway inflammation and pathology and that
loss of Ezh2 function in CD4+ T cells resulted in progressive
accumulation of Th2 cytokine-producing cells with a memory
phenotype over the life of the animal, accompanied by strong
increases in circulating IgE. Several other lines of mice with mu-
tations in genes encoding signaling molecules in T cells have
previously been reported to display similar increases in CD44hi
cells with a Th2 cell phenotype and increases in type 2 inflamma-
tion in vivo. However, in these cases, severe alterations in thymic
development (Aguado et al., 2002; Ji et al., 2007) or lymphocyte
proliferation (Ranger et al., 1998) are evident. Although the exact
mechanisms underlying the progressive Th2 cell-biased pheno-
type of SPF-maintained mice with CD4+ cell-specific deletion
of Ezh2 remain unclear, it will be important to further explore
the function of Ezh2 in other Th cell lineages, for example iTreg
cells, as well as at other Ezh2 target genes that may contribute
to Th2 cell-mediated inflammation.
In summary, we found that Ezh2 binds strongly to the master
regulators of Th1 and Th2 cell differentiation Tbx21 and Gata3,
respectively, and its presence is linked to the maintenance of
the H3K27me3 mark at these loci. Ezh2 is essential for control-
ling differentiation, cytokine production, and maintenance
of polarization of CD4+ Th cells. We also identified a pathwaymmunity 39, 819–832, November 14, 2013 ª2013 Elsevier Inc. 829
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Ezh2 Controls CD4+ T Helper Cell Differentiationregulating IFN-g production in CD4+ T cells: in the absence of
polarizing signals, Ezh2 suppresses spontaneous generation of
IFN-g-producing cells via inhibition of Eomes expression. The
findings presented herein provide a dramatic example of the
importance of Ezh2 in establishing and maintaining phenotypic
identity and indicate that without the ability to actively suppress
alternative fates via chromatin modifications, dysregulated
immune responses ensue.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 mice were from CLEA Co. Mice with loxp sites (fl) flanking the SET
domain of Ezh2 (Ezh2SET-fl/SET-fl) were generated as described (Hirabayashi
et al., 2009) and backcrossed with C57BL/6 mice for ten generations.
EomesExon1-fl/Exon1-fl mice were kindly provided by S. Reiner (Columbia Univer-
sity) (Intlekofer et al., 2008). EomesExon1-fl/Exon1-fl mice and Tbx21/ mice
(Szabo et al., 2002) were crossed with Ezh2SET-fl/SET-fl mice in our laboratory
and bred with mice expressing transgenes for Cre recombinase. CD4-Cre
mice were purchased from Taconic and OX40-Cre mice were kindly provided
by N. Killeen (UCSF) (Klinger et al., 2009). For antigen-specific activation of
CD4+ T cells, mice expressing the OTII-TCRab specific for residues 323–339
of the ovalbumin protein were used. All wild-type control mice used were
sex-matched littermates. Controls were either Ezh2SET-fl/SET-fl Cre-negative
or Ezh2wt/wt Cre-positive with similar experimental results obtained irrespec-
tive of Cre transgene expression. All mice were maintained under specific-
pathogen-free conditions and animal care was conducted in accordance
with the guidelines of Chiba University.
CD4+ T Cell Cultures
Naive (CD44loCD62Lhi) CD4+ T cell purification from spleens of mice and cul-
ture conditions for Th cell differentiation are described in the Supplemental
Experimental Procedures.
Immunofluorescent Staining for Flow-Cytometric Analysis
The antibodies used for detection of surface molecules and intracellular
staining are listed in the Supplemental Experimental Procedures. Flow cytom-
etry data was acquired on a FACSCalibur or FACSCanto flow cytometer and
results analyzed with FlowJo software (Tree Star).
Enzyme-Linked Immunosorbent Assay
A standard sandwich ELISA protocol was used to measure the concentrations
of cytokines in cell-free culture supernatants and BAL fluid samples. Antibody
pairs are listed in the Supplemental Experimental Procedures.
Knockdown Analysis
For knockdown of Gata3, the Mouse T cell Nucleofector Kit (Amaxa) was used
according to the manufacturer’s protocol. Th2 cells were transfected with 675
pmole of control random siRNA (AM4635) or siRNA for Gata3 (s66482) from
Applied Biosystems and cultured for 24 hr before analysis.
Quantitative Reverse Transcription-Polymerase Chain Reaction
RT-PCR was performed by standard protocols. A detailed description is
included in the Supplemental Experimental Procedures. Probes and primers
are listed in Table S3.
Microarray Data Collection and Analysis
Total cellular RNA was extracted with TRIzol reagent (Invitrogen). RNA was
labeled with a 30 IVT Express kit (Affymetrix) and hybridized to GeneChip
Mouse Genome 430 2.0 arrays (Affymetrix) according to the manufacturer’s
protocols. Expression values were determined with GeneChip Operating
Software (GCOS) software (Affymetrix).
Chromatin Immunoprecipitation
ChIP assays were performed as described in the Supplemental Experimental
Procedures. Polyclonal anti-Ezh2 (pAB-039-50, Diagenode), anti-H3K27me3830 Immunity 39, 819–832, November 14, 2013 ª2013 Elsevier Inc.(07-446, Millipore), anti-H3K9-Ac (06-599, Millipore), anti-H3K27ac (ab4729,
Abcam), anti-p300 (N-15 sc-548, Santa Cruz), and anti-CBP (ab2832, Abcam)
were used for immunoprecipitation. Probes and primers are listed in Table S3.
Enrichment was calculated with the following formula: (specific antibody
ChIP  control Ig ChIP)/input DNA. The highest enrichment for each antibody
was set to 10 with all other positions calculated as a function of this value.
ChIP-Sequence
Data acquisition for ChIP-sequence was performed as described previously
(Kanai et al., 2011). Read sequences were aligned to the mm9 mouse refer-
ence genome (University of California, Santa Cruz [UCSC], July 2007). Enrich-
ment values were calculated for intervals from 5 kb to +3 kb relative to the
transcriptional start site of each gene. A detailed description of the analysis
protocol is included in the Supplemental Experimental Procedures.
Mouse Model of Allergic Asthma
Th2 cell polarized Ezh2 WT or OX40-Cre-induced Ezh2DSET/DSET OT-II CD4+
cells (2 3 106) were intravenously transferred to syngeneic C57BL/6 mice.
These mice were then challenged 1 and 3 days later with aerosolized OVA
(10 mg/ml) for 30 min. BAL was performed either 12 hr (for ELISA) or 48 hr
(for analysis of airway inflammatory cells) after the last allergen challenge.
mRNA and histological analysis was performed 48 hr after the last allergen
challenge. A detailed description is included in the Supplemental Experimental
Procedures.
Statistical Analysis
Unless otherwise indicated, p values were calculated with Student’s t tests
or ANOVA with Bonferroni’s post-tests when multiple comparisons were
performed.
ACCESSION NUMBERS
ChIP-seq and microarray data are available in the Gene Expression Omnibus
(GEO) database (http://www.ncbi.nlm.nih.gov/gds) under the accession
numbers GSE51079 and GSE50729, respectively.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.immuni.2013.09.012.
ACKNOWLEDGMENTS
We thank K. Sugaya, H. Asou, M. Kato, and T. Ito for excellent technical assis-
tance. We also thank J. O’Shea for active discussion and comments on the
manuscript. This work was supported by the Global COE Program (Global
Center for Education and Research in Immune System Regulation and Treat-
ment) and by grants from the Ministry of Education, Culture, Sports, Science
and Technology (MEXT Japan) (Grants-in-Aid: for Scientific Research (B)
#21390147, (C) #24592083, Young Scientists (B) #22790452, #23790522,
#24790460, #24790461, #25860351, and #25860352, and MEXT KAKENHI
Grant Number 221S0002), the Ministry of Health, Labour and Welfare, The
Uehara Memorial Foundation, Princes Takamatsu Cancer Research Fund,
and Takeda Science Foundation. D.J.T. was supported by a Japanese Society
for the Promotion of Science postdoctoral fellowship (#2109747).
Received: January 18, 2013
Accepted: September 16, 2013
Published: November 14, 2013
REFERENCES
Aguado, E., Richelme, S., Nun˜ez-Cruz, S., Miazek, A., Mura, A.M., Richelme,
M., Guo, X.J., Sainty, D., He, H.T., Malissen, B., and Malissen, M. (2002).
Induction of T helper type 2 immunity by a point mutation in the LAT adaptor.
Science 296, 2036–2040.
Immunity
Ezh2 Controls CD4+ T Helper Cell DifferentiationAllan, R.S., Zueva, E., Cammas, F., Schreiber, H.A., Masson, V., Belz, G.T.,
Roche, D., Maison, C., Quivy, J.P., Almouzni, G., and Amigorena, S. (2012).
An epigenetic silencing pathway controlling T helper 2 cell lineage commit-
ment. Nature 487, 249–253.
Ansel, K.M., Djuretic, I., Tanasa, B., and Rao, A. (2006). Regulation of Th2 dif-
ferentiation and Il4 locus accessibility. Annu. Rev. Immunol. 24, 607–656.
Boyer, L.A., Plath, K., Zeitlinger, J., Brambrink, T., Medeiros, L.A., Lee, T.I.,
Levine, S.S., Wernig, M., Tajonar, A., Ray, M.K., et al. (2006). Polycomb com-
plexes repress developmental regulators in murine embryonic stem cells.
Nature 441, 349–353.
Di Meglio, T., Kratochwil, C.F., Vilain, N., Loche, A., Vitobello, A., Yonehara, K.,
Hrycaj, S.M., Roska, B., Peters, A.H., Eichmann, A., et al. (2013). Ezh2 orches-
trates topographic migration and connectivity of mouse precerebellar neu-
rons. Science 339, 204–207.
Ezhkova, E., Pasolli, H.A., Parker, J.S., Stokes, N., Su, I.H., Hannon, G.,
Tarakhovsky, A., and Fuchs, E. (2009). Ezh2 orchestrates gene expression
for the stepwise differentiation of tissue-specific stem cells. Cell 136, 1122–
1135.
He, S., Wang, J., Kato, K., Xie, F., Varambally, S., Mineishi, S., Kuick, R.,
Mochizuki, K., Liu, Y., Nieves, E., et al. (2012). Inhibition of histone methylation
arrests ongoing graft-versus-host disease in mice by selectively inducing
apoptosis of alloreactive effector T cells. Blood 119, 1274–1282.
Hirabayashi, Y., Suzki, N., Tsuboi, M., Endo, T.A., Toyoda, T., Shinga, J.,
Koseki, H., Vidal, M., and Gotoh, Y. (2009). Polycomb limits the neurogenic
competence of neural precursor cells to promote astrogenic fate transition.
Neuron 63, 600–613.
Hosokawa, H., Kimura, M.Y., Shinnakasu, R., Suzuki, A., Miki, T., Koseki, H.,
van Lohuizen, M., Yamashita, M., and Nakayama, T. (2006). Regulation of
Th2 cell development by Polycomb group gene bmi-1 through the stabilization
of GATA3. J. Immunol. 177, 7656–7664.
Hosokawa, H., Tanaka, T., Suzuki, Y., Iwamura, C., Ohkubo, S., Endoh, K.,
Kato, M., Endo, Y., Onodera, A., Tumes, D.J., et al. (2013). Functionally distinct
Gata3/Chd4 complexes coordinately establish T helper 2 (Th2) cell identity.
Proc. Natl. Acad. Sci. USA 110, 4691–4696.
Huang, W., Sherman, B.T., and Lempicki, R.A. (2009). Systematic and integra-
tive analysis of large gene lists using DAVID bioinformatics resources. Nat.
Protoc. 4, 44–57.
Hwang, E.S., Szabo, S.J., Schwartzberg, P.L., and Glimcher, L.H. (2005).
T helper cell fate specified by kinase-mediated interaction of T-bet with
GATA-3. Science 307, 430–433.
Intlekofer, A.M., Banerjee, A., Takemoto, N., Gordon, S.M., Dejong, C.S., Shin,
H., Hunter, C.A., Wherry, E.J., Lindsten, T., and Reiner, S.L. (2008). Anomalous
type 17 response to viral infection by CD8+ T cells lacking T-bet and eomeso-
dermin. Science 321, 408–411.
Jacob, E., Hod-Dvorai, R., Schif-Zuck, S., and Avni, O. (2008). Unconventional
association of the polycomb group proteins with cytokine genes in differenti-
ated T helper cells. J. Biol. Chem. 283, 13471–13481.
Ji, H., Rintelen, F., Waltzinger, C., Bertschy Meier, D., Bilancio, A., Pearce, W.,
Hirsch, E., Wymann, M.P., Ru¨ckle, T., Camps, M., et al. (2007). Inactivation of
PI3Kgamma and PI3Kdelta distorts T-cell development and causes multiple
organ inflammation. Blood 110, 2940–2947.
Kanai, A., Suzuki, K., Tanimoto, K., Mizushima-Sugano, J., Suzuki, Y., and
Sugano, S. (2011). Characterization of STAT6 target genes in human B cells
and lung epithelial cells. DNA Res. 18, 379–392.
Kanno, Y., Vahedi, G., Hirahara, K., Singleton, K., and O’Shea, J.J. (2012).
Transcriptional and epigenetic control of T helper cell specification: molecular
mechanisms underlying commitment and plasticity. Annu. Rev. Immunol. 30,
707–731.
Kimura, M., Koseki, Y., Yamashita, M., Watanabe, N., Shimizu, C., Katsumoto,
T., Kitamura, T., Taniguchi, M., Koseki, H., and Nakayama, T. (2001).
Regulation of Th2 cell differentiation by mel-18, a mammalian polycomb group
gene. Immunity 15, 275–287.IKlinger, M., Kim, J.K., Chmura, S.A., Barczak, A., Erle, D.J., and Killeen, N.
(2009). Thymic OX40 expression discriminates cells undergoing strong
responses to selection ligands. J. Immunol. 182, 4581–4589.
Koyanagi, M., Baguet, A., Martens, J., Margueron, R., Jenuwein, T., and Bix,
M. (2005). EZH2 and histone 3 trimethyl lysine 27 associated with Il4 and
Il13 gene silencing in Th1 cells. J. Biol. Chem. 280, 31470–31477.
Lo¨hning, M., Richter, A., and Radbruch, A. (2002). Cytokine memory of T help-
er lymphocytes. Adv. Immunol. 80, 115–181.
Makar, K.W., Pe´rez-Melgosa, M., Shnyreva, M., Weaver, W.M., Fitzpatrick,
D.R., and Wilson, C.B. (2003). Active recruitment of DNA methyltransferases
regulates interleukin 4 in thymocytes and T cells. Nat. Immunol. 4, 1183–1190.
Nakayama, T., and Yamashita, M. (2008). Initiation and maintenance of Th2
cell identity. Curr. Opin. Immunol. 20, 265–271.
O’Carroll, D., Erhardt, S., Pagani, M., Barton, S.C., Surani, M.A., and
Jenuwein, T. (2001). The polycomb-group gene Ezh2 is required for early
mouse development. Mol. Cell. Biol. 21, 4330–4336.
O’Shea, J.J., and Paul, W.E. (2010). Mechanisms underlying lineage commit-
ment and plasticity of helper CD4+ T cells. Science 327, 1098–1102.
Onodera, A., Yamashita, M., Endo, Y., Kuwahara, M., Tofukuji, S., Hosokawa,
H., Kanai, A., Suzuki, Y., and Nakayama, T. (2010). STAT6-mediated displace-
ment of polycomb by trithorax complex establishes long-term maintenance of
GATA3 expression in T helper type 2 cells. J. Exp. Med. 207, 2493–2506.
Ranger, A.M., Oukka, M., Rengarajan, J., and Glimcher, L.H. (1998). Inhibitory
function of two NFAT family members in lymphoid homeostasis and Th2
development. Immunity 9, 627–635.
Reiner, S.L. (2007). Development in motion: helper T cells at work. Cell 129,
33–36.
Schoenborn, J.R., Dorschner, M.O., Sekimata,M., Santer, D.M., Shnyreva,M.,
Fitzpatrick, D.R., Stamatoyannopoulos, J.A., and Wilson, C.B. (2007).
Comprehensive epigenetic profiling identifies multiple distal regulatory ele-
ments directing transcription of the gene encoding interferon-gamma. Nat.
Immunol. 8, 732–742.
Shen, X., Liu, Y., Hsu, Y.J., Fujiwara, Y., Kim, J., Mao, X., Yuan, G.C., and
Orkin, S.H. (2008). EZH1 mediates methylation on histone H3 lysine 27 and
complements EZH2 in maintaining stem cell identity and executing pluripo-
tency. Mol. Cell 32, 491–502.
Su, I.H., Basavaraj, A., Krutchinsky, A.N., Hobert, O., Ullrich, A., Chait, B.T.,
and Tarakhovsky, A. (2003). Ezh2 controls B cell development through histone
H3 methylation and Igh rearrangement. Nat. Immunol. 4, 124–131.
Su, I.H., Dobenecker, M.W., Dickinson, E., Oser, M., Basavaraj, A.,
Marqueron, R., Viale, A., Reinberg, D., Wu¨lfing, C., and Tarakhovsky, A.
(2005). Polycomb group protein ezh2 controls actin polymerization and cell
signaling. Cell 121, 425–436.
Suto, A., Wurster, A.L., Reiner, S.L., and Grusby, M.J. (2006). IL-21 inhibits
IFN-gamma production in developing Th1 cells through the repression of
Eomesodermin expression. J. Immunol. 177, 3721–3727.
Suzuki, A., Iwamura, C., Shinoda, K., Tumes, D.J., Kimura, M.Y., Hosokawa,
H., Endo, Y., Horiuchi, S., Tokoyoda, K., Koseki, H., et al. (2010). Polycomb
group gene product Ring1B regulates Th2-driven airway inflammation through
the inhibition of Bim-mediated apoptosis of effector Th2 cells in the lung.
J. Immunol. 184, 4510–4520.
Szabo, S.J., Kim, S.T., Costa, G.L., Zhang, X., Fathman, C.G., and Glimcher,
L.H. (2000). A novel transcription factor, T-bet, directs Th1 lineage commit-
ment. Cell 100, 655–669.
Szabo, S.J., Sullivan, B.M., Stemmann, C., Satoskar, A.R., Sleckman, B.P.,
and Glimcher, L.H. (2002). Distinct effects of T-bet in TH1 lineage commitment
and IFN-gamma production in CD4 and CD8 T cells. Science 295, 338–342.
Tan, J., Yang, X., Zhuang, L., Jiang, X., Chen,W., Lee, P.L., Karuturi, R.K., Tan,
P.B., Liu, E.T., and Yu, Q. (2007). Pharmacologic disruption of Polycomb-
repressive complex 2-mediated gene repression selectively induces apoptosis
in cancer cells. Genes Dev. 21, 1050–1063.
Thomas, R.M., Gamper, C.J., Ladle, B.H., Powell, J.D., andWells, A.D. (2012).
De novo DNA methylation is required to restrict T helper lineage plasticity.
J. Biol. Chem. 287, 22900–22909.mmunity 39, 819–832, November 14, 2013 ª2013 Elsevier Inc. 831
Immunity
Ezh2 Controls CD4+ T Helper Cell DifferentiationTofukuji, S., Kuwahara, M., Suzuki, J., Ohara, O., Nakayama, T., and
Yamashita, M. (2012). Identification of a new pathway for Th1 cell development
induced by cooperative stimulation with IL-4 and TGF-b. J. Immunol. 188,
4846–4857.
Usui, T., Nishikomori, R., Kitani, A., and Strober, W. (2003). GATA-3 sup-
presses Th1 development by downregulation of Stat4 and not through effects
on IL-12Rbeta2 chain or T-bet. Immunity 18, 415–428.
Usui, T., Preiss, J.C., Kanno, Y., Yao, Z.J., Bream, J.H., O’Shea, J.J., and
Strober, W. (2006). T-bet regulates Th1 responses through essential effects
on GATA-3 function rather than on IFNG gene acetylation and transcription.
J. Exp. Med. 203, 755–766.
Wei, G., Wei, L., Zhu, J., Zang, C., Hu-Li, J., Yao, Z., Cui, K., Kanno, Y., Roh,
T.Y., Watford, W.T., et al. (2009). Global mapping of H3K4me3 and H3K27me3
reveals specificity and plasticity in lineage fate determination of differentiating
CD4+ T cells. Immunity 30, 155–167.
Yamashita, M., Ukai-Tadenuma, M., Miyamoto, T., Sugaya, K., Hosokawa, H.,
Hasegawa, A., Kimura, M., Taniguchi, M., DeGregori, J., and Nakayama, T.
(2004). Essential role of GATA3 for the maintenance of type 2 helper T (Th2)832 Immunity 39, 819–832, November 14, 2013 ª2013 Elsevier Inc.cytokine production and chromatin remodeling at the Th2 cytokine gene
loci. J. Biol. Chem. 279, 26983–26990.
Yamashita, M., Kuwahara, M., Suzuki, A., Hirahara, K., Shinnaksu, R.,
Hosokawa, H., Hasegawa, A., Motohashi, S., Iwama, A., and Nakayama, T.
(2008). Bmi1 regulates memory CD4 T cell survival via repression of the
Noxa gene. J. Exp. Med. 205, 1109–1120.
Yang, Y., Xu, J., Niu, Y., Bromberg, J.S., and Ding, Y. (2008). T-bet and eome-
sodermin play critical roles in directing T cell differentiation to Th1 versus Th17.
J. Immunol. 181, 8700–8710.
Yu, Q., Zhou, B., Zhang, Y., Nguyen, E.T., Du, J., Glosson, N.L., and Kaplan,
M.H. (2012). DNA methyltransferase 3a limits the expression of interleukin-
13 in T helper 2 cells and allergic airway inflammation. Proc. Natl. Acad. Sci.
USA 109, 541–546.
Zheng, W., and Flavell, R.A. (1997). The transcription factor GATA-3 is neces-
sary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89,
587–596.
Zhu, J., Yamane, H., and Paul, W.E. (2010). Differentiation of effector CD4
T cell populations (*). Annu. Rev. Immunol. 28, 445–489.
